China Approves Sinopharm's Covid-19 Vaccine as it Moves to Inoculate Millions

Sinopharm, a state-controlled company, said its candidate had a 79 percent efficacy rate in interim late-stage trials. But crucial questions remained unanswered.

from NYT > Top Stories https://ift.tt/34XwraO Read about Implantation bleeding quiz https://urlzs.com/fZw6K Chlamydia in men https://urlzs.com/W3NV1 https://ift.tt/2KrY6cn https://youtu.be/QFwQ6JvyPa8